Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. META
4. ZM
5. SMTC
6. SPY
7. NCNO
8. NVDA
9. JAZZ
10. BOX

Go back to Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
Quest Diagnostics (NYSE: DGX) Delayed: 244.50 -0.01 (-0%)
Previous Close $244.51    52 Week High $86.85 
Open $244.11    52 Week Low $59.66 
Day High $246.00    P/E 46.05 
Day Low $243.49    EPS $5.31 
Volume 278,678